{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:12:36Z","timestamp":1793164356134,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["289347353 (GRK 2260)"],"award-info":[{"award-number":["289347353 (GRK 2260)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["372486779 (SFB 1340)"],"award-info":[{"award-number":["372486779 (SFB 1340)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["372486779 (SFB 1340)"],"award-info":[{"award-number":["372486779 (SFB 1340)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022805","name":"Dieter Morszeck Stiftung","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022805","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Physikalisch-Technische Bundesanstalt (PTB)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gadolinium-based contrast agents (GBCAs) have been used in clinical Magnetic Resonance Imaging (MRI) for more than 30\u00a0years. However, there is increasing evidence that their dissociation in vivo leads to long-term depositions of gadolinium ions in the human body. In vitro experiments provide critical insights into kinetics and thermodynamic equilibria of underlying processes, which give hints towards the in vivo situation. We developed a time-resolved MRI relaxometry-based approach that exploits distinct relaxivities of Gd<jats:sup>3+<\/jats:sup> in different molecular environments. Its applicability to quantify the transmetallation of GBCAs, the binding of Gd<jats:sup>3+<\/jats:sup> to competing chelators, and the combined transchelation process is demonstrated. Exemplarily, the approach is applied to investigate two representative GBCAs in the presence of Zn<jats:sup>2+<\/jats:sup> and heparin, which is used as a model for a macromolecular and physiologically occurring chelator. Opposing indirect impacts of heparin on increasing the kinetic stability but reducing the thermodynamic stability of GBCAs are observed. The relaxivity of resulting Gd-heparin complexes is shown to be essentially increased compared to that of the parent GBCAs so that they might be one explanation for observed long-term MRI signal enhancement in vivo. In forthcoming studies, the presented method could help to identify the most potent Gd-complexing macromolecular species.<\/jats:p>","DOI":"10.1038\/s41598-021-00974-4","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T11:06:21Z","timestamp":1636110381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["An NMR relaxometry approach for quantitative investigation of the transchelation of gadolinium ions from GBCAs to a competing macromolecular chelator"],"prefix":"10.1038","volume":"11","author":[{"given":"Patrick","family":"Werner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Taupitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Schuenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"974_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.rcl.2009.05.003","volume":"47","author":"HS Thomsen","year":"2009","unstructured":"Thomsen, H. S. Nephrogenic systemic fibrosis: History and epidemiology. Radiol. Clin. North Am. 47, 827\u2013831 (2009).","journal-title":"Radiol. Clin. North Am."},{"key":"974_CR2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1021\/acs.chemrev.8b00363","volume":"119","author":"J Wahsner","year":"2019","unstructured":"Wahsner, J., Gale, E. M., Rodr\u00edguez-Rodr\u00edguez, A. & Caravan, P. Chemistry of MRI contrast agents: Current challenges and new frontiers. Chem. Rev. 119, 957\u20131057 (2019).","journal-title":"Chem. Rev."},{"key":"974_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejrad.2008.01.023","volume":"66","author":"M-F Bellin","year":"2008","unstructured":"Bellin, M.-F. & Van Der Molen, A. J. Extracellular gadolinium-based contrast media: An overview. Eur. J. Radiol. 66, 160\u2013167 (2008).","journal-title":"Eur. J. Radiol."},{"key":"974_CR4","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/jmri.21966","volume":"30","author":"AD Sherry","year":"2009","unstructured":"Sherry, A. D., Caravan, P. & Lenkinski, R. E. Primer on gadolinium chemistry. J. Magn. Reson. Imaging 30, 1240\u20131248 (2009).","journal-title":"J. Magn. Reson. Imaging"},{"key":"974_CR5","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/jmri.20955","volume":"25","author":"S-P Lin","year":"2007","unstructured":"Lin, S.-P. & Brown, J. J. MR contrast agents: Physical and pharmacologic basics. J. Magn. Reson. Imaging 25, 884\u2013899 (2007).","journal-title":"J. Magn. Reson. Imaging"},{"key":"974_CR6","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1021\/cr980440x","volume":"99","author":"P Caravan","year":"1999","unstructured":"Caravan, P., Ellison, J. J., McMurry, T. J. & Lauffer, R. B. Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chem. Rev. 99, 2293\u20132352 (1999).","journal-title":"Chem. Rev."},{"key":"974_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12325-015-0275-4","volume":"33","author":"J Lohrke","year":"2016","unstructured":"Lohrke, J. et al. 25 Years of contrast-enhanced MRI: Developments, current challenges and future perspectives. Adv. Ther. 33, 1\u201328 (2016).","journal-title":"Adv. Ther."},{"key":"974_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/jmri.1184","volume":"14","author":"MA Kirchin","year":"2001","unstructured":"Kirchin, M. A., Pirovano, G., Venetianer, C. & Spinazzi, A. Safety assessment of gadobenate dimeglumine (MultiHance): Extended clinical experience from phase I studies to post-marketing surveillance. J. Magn. Reson. Imaging 14, 281\u2013294 (2001).","journal-title":"J. Magn. Reson. Imaging"},{"key":"974_CR9","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/BF00626092","volume":"38","author":"V Aslanian","year":"1996","unstructured":"Aslanian, V. et al. Evaluation of the clinical safety of gadodiamide injection, a new nonionic MRI contrast medium for the central nervous system: A European perspective. Neuroradiology 38, 537\u2013541 (1996).","journal-title":"Neuroradiology"},{"key":"974_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/01.rli.0000209657.16115.42","volume":"41","author":"MV Knopp","year":"2006","unstructured":"Knopp, M. V. et al. Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use. Invest. Radiol. 41, 491\u2013499 (2006).","journal-title":"Invest. Radiol."},{"key":"974_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/01.rli.0000248893.01067.e5","volume":"42","author":"CU Herborn","year":"2007","unstructured":"Herborn, C. U. et al. Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (Gd-DOTA). Invest. Radiol. 42, 58\u201362 (2007).","journal-title":"Invest. Radiol."},{"issue":"Suppl 5","key":"974_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/PL00006900","volume":"7","author":"VM Runge","year":"1997","unstructured":"Runge, V. M. & Parker, J. R. Worldwide clinical safety assessment of gadoteridol injection: an update. Eur. Radiol. 7(Suppl 5), 243\u2013245 (1997).","journal-title":"Eur. Radiol."},{"key":"974_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00004424-200102000-00008","volume":"36","author":"S Laurent","year":"2001","unstructured":"Laurent, S., Elst, L. V., Copoix, F. & Muller, R. N. Stability of MRI paramagnetic contrast media: A proton relaxometric protocol for transmetallation assessment. Invest. Radiol. 36, 115\u2013122 (2001).","journal-title":"Invest. Radiol."},{"key":"974_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/cmmi.388","author":"S Laurent","year":"2010","unstructured":"Laurent, S., Elst, L. V., Henoumont, C. & Muller, R. N. How to measure the transmetallation of a gadolinium complex. Contrast Media Mol. Imag. https:\/\/doi.org\/10.1002\/cmmi.388 (2010).","journal-title":"Contrast Media Mol. Imag."},{"key":"974_CR15","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3174\/ajnr.A4615","volume":"37","author":"J Ramalho","year":"2016","unstructured":"Ramalho, J. et al. Gadolinium-based contrast agent accumulation and toxicity: An update. AJNR. Am. J. Neuroradiol. 37, 1192\u20131198 (2016).","journal-title":"AJNR. Am. J. Neuroradiol."},{"key":"974_CR16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1472-8206.2006.00447.x","volume":"20","author":"J-M Id\u00e9e","year":"2006","unstructured":"Id\u00e9e, J.-M. et al. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: A review. Fundam. Clin. Pharmacol. 20, 563\u2013576 (2006).","journal-title":"Fundam. Clin. Pharmacol."},{"key":"974_CR17","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/(SICI)1521-3765(20000218)6:4<719::AID-CHEM719>3.0.CO;2-2","volume":"6","author":"L Sarka","year":"2000","unstructured":"Sarka, L., Burai, L. & Br\u00fccher, E. The rates of the exchange reactions between [Gd(DTPA)]2\u2212 and the endogenous ions Cu2+ and Zn2+: A kinetic model for the prediction of the in vivo stability of [Gd(DTPA)]2\u2212, used as a contrast agent in magnetic resonance imaging. Chem. A Eur. J. 6, 719\u2013724 (2000).","journal-title":"Chem. A Eur. J."},{"key":"974_CR18","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1148\/radiol.13131669","volume":"270","author":"T Kanda","year":"2014","unstructured":"Kanda, T., Ishii, K., Kawaguchi, H., Kitajima, K. & Takenaka, D. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: Relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 270, 834\u2013841 (2014).","journal-title":"Radiology"},{"key":"974_CR19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1148\/radiol.14140364","volume":"275","author":"T Kanda","year":"2015","unstructured":"Kanda, T. et al. High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: Association with linear versus macrocyclic gadolinium chelate administration. Radiology 275, 803\u2013809 (2015).","journal-title":"Radiology"},{"key":"974_CR20","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1148\/radiol.15150025","volume":"275","author":"RJ McDonald","year":"2015","unstructured":"McDonald, R. J. et al. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275, 772\u2013782 (2015).","journal-title":"Radiology"},{"key":"974_CR21","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1148\/radiol.2015150337","volume":"275","author":"A Radbruch","year":"2015","unstructured":"Radbruch, A. et al. Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology 275, 783\u2013791 (2015).","journal-title":"Radiology"},{"key":"974_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/jmicro\/dfm020","volume":"56","author":"C Thakral","year":"2007","unstructured":"Thakral, C. & Abraham, J. L. Automated scanning electron microscopy and x-ray microanalysis for in situ quantification of gadolinium deposits in skin. J. Electron Microsc. (Tokyo) 56, 181\u2013187 (2007).","journal-title":"J. Electron Microsc. (Tokyo)"},{"key":"974_CR23","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.mri.2013.03.025","volume":"31","author":"T Sato","year":"2013","unstructured":"Sato, T. et al. Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: Evaluation with inductively coupled plasma mass spectrometry (ICP-MS). Magn. Reson. Imaging 31, 1412\u20131417 (2013).","journal-title":"Magn. Reson. Imaging"},{"key":"974_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/01.rli.0000186569.32408.95","volume":"41","author":"GW White","year":"2006","unstructured":"White, G. W., Gibby, W. A. & Tweedle, M. F. Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. Invest. Radiol. 41, 272\u2013278 (2006).","journal-title":"Invest. Radiol."},{"key":"974_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/archophthalmol.2011.89","volume":"129","author":"A Barker-Griffith","year":"2011","unstructured":"Barker-Griffith, A., Goldberg, J. & Abraham, J. L. Ocular pathologic features and gadolinium deposition in nephrogenic systemic fibrosis. Arch. Ophthalmol. Chicago 129, 661\u2013663 (2011).","journal-title":"Arch. Ophthalmol. Chicago"},{"key":"974_CR26","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1093\/ndt\/gfr085","volume":"26","author":"S Sanyal","year":"2011","unstructured":"Sanyal, S., Marckmann, P., Scherer, S. & Abraham, J. L. Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis\u2013an autopsy-based review. Nephrol. Dial. Transplant 26, 3616\u20133626 (2011).","journal-title":"Nephrol. Dial. Transplant"},{"key":"974_CR27","first-page":"534","volume":"5","author":"Y-XJ W\u00e1ng","year":"2015","unstructured":"W\u00e1ng, Y.-X.J. et al. Total gadolinium tissue deposition and skin structural findings following the administration of structurally different gadolinium chelates in healthy and ovariectomized female rats. Quant. Imaging Med. Surg. 5, 534\u2013545 (2015).","journal-title":"Quant. Imaging Med. Surg."},{"key":"974_CR28","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/jmri.25822","volume":"47","author":"S Bussi","year":"2018","unstructured":"Bussi, S. et al. Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats. J. Magn. Reson. Imaging 47, 746\u2013752 (2018).","journal-title":"J. Magn. Reson. Imaging"},{"key":"974_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ejic.201801220","volume":"2019","author":"E Gianolio","year":"2019","unstructured":"Gianolio, E., Gregorio, E. D. & Aime, S. Chemical insights into the issues of Gd retention in the brain and other tissues upon the administration of Gd-containing MRI contrast agents. Eur. J. Inorg. Chem. 2019, 137\u2013151 (2019).","journal-title":"Eur. J. Inorg. Chem."},{"key":"974_CR30","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1148\/radiol.2018172746","volume":"288","author":"P Robert","year":"2018","unstructured":"Robert, P. et al. One-year retention of gadolinium in the brain: Comparison of gadodiamide and gadoterate meglumine in a rodent model. Radiology 288, 424\u2013433 (2018).","journal-title":"Radiology"},{"key":"974_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/cmmi.1500","volume":"8","author":"M Taupitz","year":"2013","unstructured":"Taupitz, M. et al. Gadolinium-containing magnetic resonance contrast media: Investigation on the possible transchelation of Gd3+ to the glycosaminoglycan heparin. Contrast Media Mol. Imag. 8, 108\u2013116 (2013).","journal-title":"Contrast Media Mol. Imag."},{"key":"974_CR32","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0021-9258(18)91342-6","volume":"239","author":"PT Dogaganes","year":"1964","unstructured":"Dogaganes, P. T. & Schubert, M. The use of lanthanum to study the degradation of a proteinpolysaccharide from cartilage. J. Biol. Chem. 239, 1498\u20131503 (1964).","journal-title":"J. Biol. Chem."},{"key":"974_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0047-0740(83)90026-8","volume":"10","author":"A Ando","year":"1983","unstructured":"Ando, A., Ando, I., Hiraki, T., Takeshita, M. & Hisada, K. Mechanism of tumor and liver concentration of 67Ga: 67Ga binding substances in tumor tissues and liver. Int. J. Nucl. Med. Biol. 10, 1\u20139 (1983).","journal-title":"Int. J. Nucl. Med. Biol."},{"key":"974_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0008-6215(90)84044-U","volume":"207","author":"RN Rej","year":"1990","unstructured":"Rej, R. N., Holme, K. R. & Perlin, A. S. Marked stereoselectivity in the binding of copper ions by heparin. Contrasts with the binding of gadolinium and calcium ions. Carbohydr. Res. 207, 143\u2013152 (1990).","journal-title":"Carbohydr. Res."},{"key":"974_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0008-6215(95)00263-4","volume":"278","author":"DL Rabenstein","year":"1995","unstructured":"Rabenstein, D. L., Robert, J. M. & Peng, J. Multinuclear magnetic resonance studies of the interaction of inorganic cations with heparin. Carbohydr. Res. 278, 239\u2013256 (1995).","journal-title":"Carbohydr. Res."},{"key":"974_CR36","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1039\/C8MT00159F","volume":"10","author":"AIS Sobczak","year":"2018","unstructured":"Sobczak, A. I. S., Pitt, S. J. & Stewart, A. J. Influence of zinc on glycosaminoglycan neutralisation during coagulation. Metallomics 10, 1180\u20131190 (2018).","journal-title":"Metallomics"},{"key":"974_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1042\/bj2370281","volume":"237","author":"NE Woodhead","year":"1986","unstructured":"Woodhead, N. E., Long, W. F. & Williamson, F. B. Binding of zinc ions to heparin. Analysis by equilibrium dialysis suggests the occurrence of two, entropy-driven, processes. Biochem. J. 237, 281\u2013284 (1986).","journal-title":"Biochem. J."},{"key":"974_CR38","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/01.rli.0000184756.66360.d3","volume":"40","author":"M Rohrer","year":"2005","unstructured":"Rohrer, M., Bauer, H., Mintorovitch, J., Requardt, M. & Weinmann, H.-J. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest. Radiol. 40, 715\u2013724 (2005).","journal-title":"Invest. Radiol."},{"key":"974_CR39","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10858-013-9728-8","volume":"58","author":"C Luchinat","year":"2014","unstructured":"Luchinat, C., Parigi, G. & Ravera, E. Can metal ion complexes be used as polarizing agents for solution DNP? A theoretical discussion. J. Biomol. NMR 58, 239\u2013249 (2014).","journal-title":"J. Biomol. NMR"},{"key":"974_CR40","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.1021\/ja1099616","volume":"133","author":"DJ Mastarone","year":"2011","unstructured":"Mastarone, D. J. et al. A modular system for the synthesis of multiplexed magnetic resonance probes. J. Am. Chem. Soc. 133, 5329\u20135337 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"974_CR41","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1039\/C8BM00346G","volume":"6","author":"H Lajous","year":"2018","unstructured":"Lajous, H. et al. Hybrid Gd3+\/cisplatin cross-linked polymer nanoparticles enhance platinum accumulation and formation of DNA adducts in glioblastoma cell lines. Biomater. Sci. 6, 2386\u20132409 (2018).","journal-title":"Biomater. Sci."},{"key":"974_CR42","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1039\/C8BM01103F","volume":"7","author":"S Guo","year":"2019","unstructured":"Guo, S. et al. Reductive microenvironment responsive gadolinium-based polymers as potential safe MRI contrast agents. Biomater. Sci. 7, 1919\u20131932 (2019).","journal-title":"Biomater. Sci."},{"key":"974_CR43","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1039\/C7BM00126F","volume":"5","author":"X Zhou","year":"2017","unstructured":"Zhou, X. et al. Enhancing MRI of liver metastases with a zwitterionized biodegradable dendritic contrast agent. Biomater. Sci. 5, 1588\u20131595 (2017).","journal-title":"Biomater. Sci."},{"key":"974_CR44","doi-asserted-by":"publisher","DOI":"10.1039\/d0bm00827c","author":"H Su","year":"2020","unstructured":"Su, H. et al. Theranostic supramolecular polymers formed by self-assembly of a metal-chelating prodrug. Biomater. Sci. https:\/\/doi.org\/10.1039\/d0bm00827c (2020).","journal-title":"Biomater. Sci."},{"key":"974_CR45","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/jmri.21969","volume":"30","author":"S Aime","year":"2009","unstructured":"Aime, S. & Caravan, P. Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. J. Magn. Reson. Imaging 30, 1259\u20131267 (2009).","journal-title":"J. Magn. Reson. Imaging"},{"key":"974_CR46","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1039\/C8MT00302E","volume":"11","author":"M Le Fur","year":"2019","unstructured":"Le Fur, M. & Caravan, P. The biological fate of gadolinium-based MRI contrast agents: A call to action for bioinorganic chemists. Metallomics 11, 240\u2013254 (2019).","journal-title":"Metallomics"},{"key":"974_CR47","doi-asserted-by":"crossref","unstructured":"Garcia, J., Liu, S. Z. & Louie, A. Y. Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus. Philos. Trans. A. Math. Phys. Eng. Sci. 375, (2017).","DOI":"10.1098\/rsta.2017.0180"},{"key":"974_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-bioeng-071516-044610","volume":"19","author":"D Soares da Costa","year":"2017","unstructured":"Soares da Costa, D., Reis, R. L. & Pashkuleva, I. Sulfation of glycosaminoglycans and its implications in human health and disorders. Annu. Rev. Biomed. Eng. 19, 1\u201326 (2017).","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"974_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1096\/fj.05-4682rev","volume":"20","author":"KR Taylor","year":"2006","unstructured":"Taylor, K. R. & Gallo, R. L. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 20, 9\u201322 (2006).","journal-title":"FASEB J."},{"key":"974_CR50","first-page":"435","volume":"8","author":"C Friman","year":"1977","unstructured":"Friman, C., Storg\u00e5rds, E., Juvani, M. & Kock, B. The glycosaminoglycans (mucopolysaccharides) in plasma in patients with renal insufficiency. Clin. Nephrol. 8, 435\u2013439 (1977).","journal-title":"Clin. Nephrol."},{"key":"974_CR51","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/S0140-6736(00)02694-5","volume":"356","author":"SE Cowper","year":"2000","unstructured":"Cowper, S. E. et al. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet (London, England) 356, 1000\u20131001 (2000).","journal-title":"Lancet (London, England)"},{"key":"974_CR52","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3109\/10408444.2014.955568","volume":"44","author":"J-M Id\u00e9e","year":"2014","unstructured":"Id\u00e9e, J.-M., Fretellier, N., Robic, C. & Corot, C. The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update. Crit. Rev. Toxicol. 44, 895\u2013913 (2014).","journal-title":"Crit. Rev. Toxicol."},{"key":"974_CR53","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/RLI.0000000000000462","volume":"53","author":"J Endrikat","year":"2018","unstructured":"Endrikat, J. et al. 10 years of nephrogenic systemic fibrosis: A comprehensive analysis of nephrogenic systemic fibrosis reports received by a pharmaceutical company from 2006 to 2016. Invest. Radiol. 53, 541\u2013550 (2018).","journal-title":"Invest. Radiol."},{"key":"974_CR54","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/ajcn\/25.7.672","volume":"25","author":"LD McBean","year":"1972","unstructured":"McBean, L. D., Dove, J. T., Halsted, J. A. & Smith, J. C. Zinc concentration in human tissues. Am. J. Clin. Nutr. 25, 672\u2013676 (1972).","journal-title":"Am. J. Clin. Nutr."},{"key":"974_CR55","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1042\/bj0910424","volume":"91","author":"R Parr","year":"1964","unstructured":"Parr, R. & Taylor, D. The concentrations of cobalt, copper, iron and zinc in some normal human tissues as determined by neutron-activation analysis. Biochem. J. 91, 424\u2013431 (1964).","journal-title":"Biochem. J."},{"key":"974_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22020667","volume":"22","author":"E Rudolf","year":"2021","unstructured":"Rudolf, E. & Rudolf, K. Acute increases in intracellular zinc lead to an increased lysosomal and mitochondrial autophagy and subsequent cell demise in malignant melanoma. Int. J. Mol. Sci. 22, 1\u201319 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"974_CR57","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/elps.201100185","volume":"32","author":"M Andr\u00e1si","year":"2011","unstructured":"Andr\u00e1si, M. et al. Determination of gadolinium-based magnetic resonance imaging contrast agents by micellar electrokinetic capillary chromatography. Electrophoresis 32, 2223\u20132228 (2011).","journal-title":"Electrophoresis"},{"key":"974_CR58","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1021\/ic100150e","volume":"49","author":"T Atanasijevic","year":"2010","unstructured":"Atanasijevic, T., Zhang, X., Lippard, S. J. & Jasanoff, A. MRI sensing based on the displacement of paramagnetic ions from chelated complexes. Inorg. Chem. 49, 2589\u20132591 (2010).","journal-title":"Inorg. Chem."},{"key":"974_CR59","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1002\/anie.201510956","volume":"55","author":"G Angelovski","year":"2016","unstructured":"Angelovski, G. What we can really do with bioresponsive MRI contrast agents. Angew. Chemie Int. Ed. 55, 7038\u20137046 (2016).","journal-title":"Angew. Chemie Int. Ed."},{"key":"974_CR60","doi-asserted-by":"publisher","first-page":"9065","DOI":"10.1021\/acsabm.0c01295","volume":"3","author":"F Carniato","year":"2020","unstructured":"Carniato, F. et al. 1H NMR relaxometric study of chitosan-based nanogels containing mono- and bis-hydrated Gd(III) chelates: Clues for MRI probes of improved sensitivity. ACS Appl. Bio Mater. 3, 9065\u20139072 (2020).","journal-title":"ACS Appl. Bio Mater."},{"key":"974_CR61","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1039\/C6TB00832A","volume":"4","author":"L Ternent","year":"2016","unstructured":"Ternent, L., Mayoh, D. A., Lees, M. R. & Davies, G. L. Heparin-stabilised iron oxide for MR applications: A relaxometric study. J. Mater. Chem. B 4, 3065\u20133074 (2016).","journal-title":"J. Mater. Chem. B"},{"key":"974_CR62","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1021\/ja710172z","volume":"130","author":"SA Corr","year":"2008","unstructured":"Corr, S. A. et al. Linear assemblies of magnetic nanoparticles as MRI contrast agents. J. Am. Chem. Soc. 130, 4214\u20134215 (2008).","journal-title":"J. Am. Chem. Soc."},{"key":"974_CR63","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/cphc.201000853","volume":"12","author":"G-L Davies","year":"2011","unstructured":"Davies, G.-L. et al. NMR relaxation of water in nanostructures: Analysis of ferromagnetic cobalt-ferrite polyelectrolyte nanocomposites. ChemPhysChem 12, 772\u2013776 (2011).","journal-title":"ChemPhysChem"},{"key":"974_CR64","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1039\/C0JM01061H","volume":"21","author":"CJ Meledandri","year":"2011","unstructured":"Meledandri, C. J., Ninjbadgar, T. & Brougham, D. F. Size-controlled magnetoliposomes with tunable magnetic resonance relaxation enhancements. J. Mater. Chem. 21, 214\u2013222 (2011).","journal-title":"J. Mater. Chem."},{"key":"974_CR65","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/(SICI)1099-0682(200003)2000:3<399::AID-EJIC399>3.0.CO;2-B","volume":"2000","author":"M Botta","year":"2000","unstructured":"Botta, M. Second coordination sphere water molecules and relaxivity of gadolinium(III) complexes: Implications for MRI contrast agents. Eur. J. Inorg. Chem. 2000, 399 (2000).","journal-title":"Eur. J. Inorg. Chem."},{"key":"974_CR66","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1021\/nn5070953","volume":"9","author":"MW Rotz","year":"2015","unstructured":"Rotz, M. W. et al. High relaxivity Gd(III)-DNA gold nanostars: Investigation of shape effects on proton relaxation. ACS Nano 9, 3385\u20133396 (2015).","journal-title":"ACS Nano"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00974-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00974-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00974-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T17:08:26Z","timestamp":1670087306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00974-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["974"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-00974-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"assertion":[{"value":"5 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21731"}}